IMM 6.25% 30.0¢ immutep limited

Immutep (ASX:IMM) clinical trial update @July 02, 2019 02:45 PM, page-10

  1. 75 Posts.
    lightbulb Created with Sketch. 9
    Suckers wanted.

    An opportunity exists for optimistic investors to invest in IMM.
    You must see high potential in all of our announcements and be willing to be strung along when things don't go quite the way they were planned.
    (Of course this would be very rare in the biomed space.)
    You must be willing to look at the long term graph and convince yourself this is the "one".
    You must also be prepared to partake in all share purchase plans and further liquidate the crap out of this stock.
    Extreme patience is also desirable.
    Apply now by buying as many shares as possible, there is no need to exercise due diligence, just get on board it may take off.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.020(6.25%)
Mkt cap ! $435.7M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $2.355M 7.796M

Buyers (Bids)

No. Vol. Price($)
8 128197 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.